Maranga Innocent O, Hampson Lynne, Oliver Anthony W, He Xiaotong, Gichangi Peter, Rana Farzana, Opiyo Anselmy, Hampson Ian N
Viral Oncology Laboratories, University of Manchester Institute of Cancer Sciences, Research Floor 5, St Mary's Hospital, Manchester, M13 9WL, UK ; Departments of Obstetrics and Gynaecology, University of Nairobi, Nairobi, Kenya.
Open Virol J. 2013;7:19-27. doi: 10.2174/1874357901307010019. Epub 2013 Feb 25.
Infection with high risk HPV is implicated in pre-cancerous squamous intraepithelial lesions and their progression to cervical cancer. In the developed countries, infection with HPV 16 and 18 accounts for 70% of cervical cancers, but it has been established that HPV type prevalence differs according to worldwide geographical location. In sub Saharan Africa infection with HPV is known to be augmented by HIV, which is endemic in this region. It is not yet clear, however, whether this ultimately influences progression to cervical cancer. Papillocheck(TM) and multiplex PCR were used to determine the range of HPV genotypes found in cervical smears and carcinomas from HIV positive and negative Kenyan women. Smear samples from HIV-positive women had a higher prevalence of: multiple HPV infections; high-risk HPVs 52, 58, 68, potential high risk 53/70, low-risk 44/55 and abnormal cytology compared to HIV-negative women. A low overall prevalence (8%) of types 16/18 was found in all smear samples tested (n = 224) although this increased in invasive cervical carcinoma tissues to ~80% for HIV-negative and ~46% for HIV-positive women. Furthermore, HPV45 was more common in cervical carcinoma tissues from HIV-positive women. In summary HIV infection appears to alter the spectrum of HPV types found in both cervical smears and invasive cervical carcinomas. It is hypothesised there could be a complex interplay between these viruses which could either positively or negatively influence the rate of progression to cervical cancer.
高危型人乳头瘤病毒(HPV)感染与癌前鳞状上皮内病变及其进展为宫颈癌有关。在发达国家,HPV 16和18型感染约占宫颈癌的70%,但已确定HPV类型的流行率因全球地理位置而异。在撒哈拉以南非洲,已知HIV会增加HPV感染,而HIV在该地区呈地方性流行。然而,目前尚不清楚这最终是否会影响宫颈癌的进展。使用Papillocheck(TM)和多重PCR来确定在肯尼亚HIV阳性和阴性女性的宫颈涂片和癌组织中发现的HPV基因型范围。与HIV阴性女性相比,HIV阳性女性的涂片样本中以下情况的患病率更高:多种HPV感染;高危型HPV 52、58、68型,潜在高危型53/70型,低危型44/55型以及异常细胞学。在所有检测的涂片样本(n = 224)中,16/18型的总体患病率较低(约8%),尽管在浸润性宫颈癌组织中,HIV阴性女性的这一比例增加到约80%,HIV阳性女性增加到约46%。此外,HPV45在HIV阳性女性的宫颈癌组织中更为常见。总之,HIV感染似乎会改变在宫颈涂片和浸润性宫颈癌中发现的HPV类型谱。据推测,这些病毒之间可能存在复杂的相互作用,这可能对宫颈癌的进展速度产生正面或负面影响。